We're building a new type of biocomputer that bridges nature and silicon, calculating better solutions to death and disease.
Fully automated, massively parallelized, we’re running in vivo studies with speed, rigor, and scale. A Pareto-efficient search of drug candidates and truly meaningful validation — all-too-absent in status-quo pharmacology — will slash cost, time-to-market, and time-to-patient.
Interested in running an experiment with the same ease of hitting compile?
Thanks for signing up!
Thanks! We're excited to share updates on what we're building, soon!